<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />

<meta name="viewport" content="width=device-width, initial-scale=1" />

<meta name="author" content="Johannes Cepicka" />


<title>Fixed effect estimates and prior distributions</title>

<script>// Pandoc 2.9 adds attributes on both header and div. We remove the former (to
// be compatible with the behavior of Pandoc < 2.8).
document.addEventListener('DOMContentLoaded', function(e) {
  var hs = document.querySelectorAll("div.section[class*='level'] > :first-child");
  var i, h, a;
  for (i = 0; i < hs.length; i++) {
    h = hs[i];
    if (!/^h[1-6]$/i.test(h.tagName)) continue;  // it should be a header h1-h6
    a = h.attributes;
    while (a.length > 0) h.removeAttribute(a[0].name);
  }
});
</script>

<style type="text/css">
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
span.underline{text-decoration: underline;}
div.column{display: inline-block; vertical-align: top; width: 50%;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
</style>



<style type="text/css">
code {
white-space: pre;
}
.sourceCode {
overflow: visible;
}
</style>
<style type="text/css" data-origin="pandoc">
pre > code.sourceCode { white-space: pre; position: relative; }
pre > code.sourceCode > span { line-height: 1.25; }
pre > code.sourceCode > span:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode > span { color: inherit; text-decoration: inherit; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
pre > code.sourceCode { white-space: pre-wrap; }
pre > code.sourceCode > span { text-indent: -5em; padding-left: 5em; }
}
pre.numberSource code
{ counter-reset: source-line 0; }
pre.numberSource code > span
{ position: relative; left: -4em; counter-increment: source-line; }
pre.numberSource code > span > a:first-child::before
{ content: counter(source-line);
position: relative; left: -1em; text-align: right; vertical-align: baseline;
border: none; display: inline-block;
-webkit-touch-callout: none; -webkit-user-select: none;
-khtml-user-select: none; -moz-user-select: none;
-ms-user-select: none; user-select: none;
padding: 0 4px; width: 4em;
color: #aaaaaa;
}
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa; padding-left: 4px; }
div.sourceCode
{ }
@media screen {
pre > code.sourceCode > span > a:first-child::before { text-decoration: underline; }
}
code span.al { color: #ff0000; font-weight: bold; } 
code span.an { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.at { color: #7d9029; } 
code span.bn { color: #40a070; } 
code span.bu { color: #008000; } 
code span.cf { color: #007020; font-weight: bold; } 
code span.ch { color: #4070a0; } 
code span.cn { color: #880000; } 
code span.co { color: #60a0b0; font-style: italic; } 
code span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.do { color: #ba2121; font-style: italic; } 
code span.dt { color: #902000; } 
code span.dv { color: #40a070; } 
code span.er { color: #ff0000; font-weight: bold; } 
code span.ex { } 
code span.fl { color: #40a070; } 
code span.fu { color: #06287e; } 
code span.im { color: #008000; font-weight: bold; } 
code span.in { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.kw { color: #007020; font-weight: bold; } 
code span.op { color: #666666; } 
code span.ot { color: #007020; } 
code span.pp { color: #bc7a00; } 
code span.sc { color: #4070a0; } 
code span.ss { color: #bb6688; } 
code span.st { color: #4070a0; } 
code span.va { color: #19177c; } 
code span.vs { color: #4070a0; } 
code span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } 
</style>
<script>
// apply pandoc div.sourceCode style to pre.sourceCode instead
(function() {
  var sheets = document.styleSheets;
  for (var i = 0; i < sheets.length; i++) {
    if (sheets[i].ownerNode.dataset["origin"] !== "pandoc") continue;
    try { var rules = sheets[i].cssRules; } catch (e) { continue; }
    var j = 0;
    while (j < rules.length) {
      var rule = rules[j];
      // check if there is a div.sourceCode rule
      if (rule.type !== rule.STYLE_RULE || rule.selectorText !== "div.sourceCode") {
        j++;
        continue;
      }
      var style = rule.style.cssText;
      // check if color or background-color is set
      if (rule.style.color === '' && rule.style.backgroundColor === '') {
        j++;
        continue;
      }
      // replace div.sourceCode by a pre.sourceCode rule
      sheets[i].deleteRule(j);
      sheets[i].insertRule('pre.sourceCode{' + style + '}', j);
    }
  }
})();
</script>




<style type="text/css">body {
background-color: #fff;
margin: 1em auto;
max-width: 700px;
overflow: visible;
padding-left: 2em;
padding-right: 2em;
font-family: "Open Sans", "Helvetica Neue", Helvetica, Arial, sans-serif;
font-size: 14px;
line-height: 1.35;
}
#TOC {
clear: both;
margin: 0 0 10px 10px;
padding: 4px;
width: 400px;
border: 1px solid #CCCCCC;
border-radius: 5px;
background-color: #f6f6f6;
font-size: 13px;
line-height: 1.3;
}
#TOC .toctitle {
font-weight: bold;
font-size: 15px;
margin-left: 5px;
}
#TOC ul {
padding-left: 40px;
margin-left: -1.5em;
margin-top: 5px;
margin-bottom: 5px;
}
#TOC ul ul {
margin-left: -2em;
}
#TOC li {
line-height: 16px;
}
table {
margin: 1em auto;
border-width: 1px;
border-color: #DDDDDD;
border-style: outset;
border-collapse: collapse;
}
table th {
border-width: 2px;
padding: 5px;
border-style: inset;
}
table td {
border-width: 1px;
border-style: inset;
line-height: 18px;
padding: 5px 5px;
}
table, table th, table td {
border-left-style: none;
border-right-style: none;
}
table thead, table tr.even {
background-color: #f7f7f7;
}
p {
margin: 0.5em 0;
}
blockquote {
background-color: #f6f6f6;
padding: 0.25em 0.75em;
}
hr {
border-style: solid;
border: none;
border-top: 1px solid #777;
margin: 28px 0;
}
dl {
margin-left: 0;
}
dl dd {
margin-bottom: 13px;
margin-left: 13px;
}
dl dt {
font-weight: bold;
}
ul {
margin-top: 0;
}
ul li {
list-style: circle outside;
}
ul ul {
margin-bottom: 0;
}
pre, code {
background-color: #f7f7f7;
border-radius: 3px;
color: #333;
white-space: pre-wrap; 
}
pre {
border-radius: 3px;
margin: 5px 0px 10px 0px;
padding: 10px;
}
pre:not([class]) {
background-color: #f7f7f7;
}
code {
font-family: Consolas, Monaco, 'Courier New', monospace;
font-size: 85%;
}
p > code, li > code {
padding: 2px 0px;
}
div.figure {
text-align: center;
}
img {
background-color: #FFFFFF;
padding: 2px;
border: 1px solid #DDDDDD;
border-radius: 3px;
border: 1px solid #CCCCCC;
margin: 0 5px;
}
h1 {
margin-top: 0;
font-size: 35px;
line-height: 40px;
}
h2 {
border-bottom: 4px solid #f7f7f7;
padding-top: 10px;
padding-bottom: 2px;
font-size: 145%;
}
h3 {
border-bottom: 2px solid #f7f7f7;
padding-top: 10px;
font-size: 120%;
}
h4 {
border-bottom: 1px solid #f7f7f7;
margin-left: 8px;
font-size: 105%;
}
h5, h6 {
border-bottom: 1px solid #ccc;
font-size: 105%;
}
a {
color: #0033dd;
text-decoration: none;
}
a:hover {
color: #6666ff; }
a:visited {
color: #800080; }
a:visited:hover {
color: #BB00BB; }
a[href^="http:"] {
text-decoration: underline; }
a[href^="https:"] {
text-decoration: underline; }

code > span.kw { color: #555; font-weight: bold; } 
code > span.dt { color: #902000; } 
code > span.dv { color: #40a070; } 
code > span.bn { color: #d14; } 
code > span.fl { color: #d14; } 
code > span.ch { color: #d14; } 
code > span.st { color: #d14; } 
code > span.co { color: #888888; font-style: italic; } 
code > span.ot { color: #007020; } 
code > span.al { color: #ff0000; font-weight: bold; } 
code > span.fu { color: #900; font-weight: bold; } 
code > span.er { color: #a61717; background-color: #e3d2d2; } 
</style>




</head>

<body>




<h1 class="title toc-ignore">Fixed effect estimates and prior
distributions</h1>
<h4 class="author">Johannes Cepicka</h4>



<p>Suppose we are planning a drug development program testing the
superiority of an experimental treatment over a control treatment. Our
drug development program consists of an exploratory phase II trial which
is, in case of promising results, followed by a confirmatory phase III
trial.</p>
<p>The drugdevelopR package enables us to optimally plan such programs
using a utility-maximizing approach. Up until now, we presented a very
basic example on how the package works in <a href="https://sterniii3.github.io/drugdevelopR/articles/Introduction-to-drugdevelopR.html">Introduction
to planning phase II and phase III trials with drugdevelopR</a>. In this
article, we want to expand the basic setting and want to introduce you
to the modelling of the assumed treatment effect on a prior
distribution.</p>
<div id="the-example-setting" class="section level1">
<h1>The example setting</h1>
<p>We are in the same setting as in the introduction, i.e. we suppose we
are developing a new tumor treatment, <em>exper</em>. The patient
variable that we want to investigate is the difference in tumor width
between the one-year visit and baseline. This is a normally distributed
outcome variable.</p>
<p>The parameters we insert into the function
<code>optimum_normal</code> are the same parameters we also inserted in
the basic setting. However this time, we set <code>fixed</code> =
<code>&quot;FALSE&quot;</code>, hence the assumed true treatment effect is not
fixed but follows a prior distribution. Again, we start by loading the
drugdevelopR package.</p>
<div class="sourceCode" id="cb1"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb1-1"><a href="#cb1-1" tabindex="-1"></a><span class="fu">library</span>(drugdevelopR)</span></code></pre></div>
<div id="parameters-of-the-prior-distribution" class="section level2">
<h2>Parameters of the prior distribution</h2>
<p>Additionally to the parameters in the baseline scenario with fixed
treatment effects, we now need further input parameters:</p>
<ul>
<li>Differing from the baseline scenario we now have not only one
treatment effect, but two: <code>Delta1</code> and <code>Delta2</code>.
The input parameter <code>Delta1</code> is the one we got from some
randomized controlled pilot trial that our team conducted earlier. Its
value is given as the standardized difference in means (<span class="math inline">\(\Delta=\frac{\mu_{contro} -
\mu_{exper}}{\sigma}\)</span>) and its value was determined to be 0.625.
However, we are not so sure about this result, as another research group
conducted a similar study and got an treatment effect of 0.9, which will
now be our value for <code>Delta2</code>. Of course, the choice of <span class="math inline">\(\Delta_1\)</span> and <span class="math inline">\(\Delta_2\)</span> need not be built on two
clinical studies, but can also be derived from different sources for
forming a prior belief, e.g. clinical experience.</li>
<li>We now have to specify how sure we are about the two prior beliefs
<span class="math inline">\(\Delta_1\)</span> and <span class="math inline">\(\Delta_2\)</span>. This is done by the two
additional parameters <code>in1</code> and <code>in2</code>. We call
these parameters the “amount of information”. They refer to the sample
sizes of the studies on which we base our prior beliefs. If our pilot
study was conducted with 300 participants, the value for
<code>in1</code> is set to be 300. Let’s assume that the study of the
other research group was conducted with 600 participants, so the
parameter value for <code>in2</code> is 600. The higher amount of
information, the lower the variance we attribute to that prior
belief.</li>
<li>Now, a weight parameter <code>w</code> has to be defined, that
allows us to weigh the two treatment effects. If we want to trust our
results more, than we can set a higher parameter value for
<code>w</code>. (Note that <code>w</code> has to be between 0 and 1, a
parameter value of 1 would put all the weight on our results and none on
the results of the second study). If we think the results of the other
group are more reliable we reduce the value for w, thus putting more
weight on <code>Delta2</code>. Note that by exchanging the values of
<code>Delta1</code> and <code>Delta2</code> (and the corresponding
values for <code>in1</code> and <code>in2</code>) and setting <span class="math inline">\(w_{new} = 1 - w_{old}\)</span> our final results
will not change. In our case, we want to put more trust on our results
and thus set the parameter <code>w</code> to be 0.6. Setting the weight
to <span class="math inline">\(1\)</span> would effectively mean
ignoring the second treatment effect, which is also possible.</li>
<li>The prior distribution used in the package is the sum of two
truncated normal distributions. Hence, we need truncation values
<code>a</code> as the lower boundary for the truncation and
<code>b</code> as the upper boundary. In our case we set
<code>a = 0.25</code> and <code>b = 0.75</code>.</li>
</ul>
<p>The prior distribution for the standardized true difference in means
is then given by <span class="math inline">\(\Delta ∼ w ·
\mathcal{N}^t_{[0.25,0.75]} (0.625, 4/300) + (1 − w) ·
\mathcal{N}^t_{[0.25,0.75]} (0.9, 4/600)\)</span> where <span class="math inline">\(N^t_{[a,b]} (\mu, \sigma^2)\)</span> denotes the
truncated normal distribution with mean <span class="math inline">\(\mu\)</span>, variance <span class="math inline">\(\sigma^2\)</span>, truncated below at a and above
at b. To see how different input values change the prior distribution we
refer to the <a href="https://web.imbi.uni-heidelberg.de/prior/">Shiny
app</a>.</p>
<div class="sourceCode" id="cb2"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb2-1"><a href="#cb2-1" tabindex="-1"></a> res <span class="ot">&lt;-</span> <span class="fu">optimal_normal</span>(<span class="at">Delta1 =</span> <span class="fl">0.625</span>, <span class="at">Delta2 =</span> <span class="fl">0.8</span>, <span class="at">fixed =</span> <span class="cn">FALSE</span>, <span class="co"># treatment effect</span></span>
<span id="cb2-2"><a href="#cb2-2" tabindex="-1"></a>                       <span class="at">n2min =</span> <span class="dv">20</span>, <span class="at">n2max =</span> <span class="dv">400</span>, <span class="co"># sample size region</span></span>
<span id="cb2-3"><a href="#cb2-3" tabindex="-1"></a>                       <span class="at">stepn2 =</span> <span class="dv">4</span>, <span class="co"># sample size step size</span></span>
<span id="cb2-4"><a href="#cb2-4" tabindex="-1"></a>                       <span class="at">kappamin =</span> <span class="fl">0.02</span>, <span class="at">kappamax =</span> <span class="fl">0.2</span>, <span class="co"># threshold region</span></span>
<span id="cb2-5"><a href="#cb2-5" tabindex="-1"></a>                       <span class="at">stepkappa =</span> <span class="fl">0.02</span>, <span class="co"># threshold step size</span></span>
<span id="cb2-6"><a href="#cb2-6" tabindex="-1"></a>                       <span class="at">c2 =</span> <span class="fl">0.675</span>, <span class="at">c3 =</span> <span class="fl">0.72</span>, <span class="co"># maximal total trial costs</span></span>
<span id="cb2-7"><a href="#cb2-7" tabindex="-1"></a>                       <span class="at">c02 =</span> <span class="dv">15</span>, <span class="at">c03 =</span> <span class="dv">20</span>, <span class="co"># maximal per-patient costs</span></span>
<span id="cb2-8"><a href="#cb2-8" tabindex="-1"></a>                       <span class="at">b1 =</span> <span class="dv">3000</span>, <span class="at">b2 =</span> <span class="dv">8000</span>, <span class="at">b3 =</span> <span class="dv">10000</span>, <span class="co"># gains for patients</span></span>
<span id="cb2-9"><a href="#cb2-9" tabindex="-1"></a>                       <span class="at">alpha =</span> <span class="fl">0.025</span>, <span class="co"># significance level</span></span>
<span id="cb2-10"><a href="#cb2-10" tabindex="-1"></a>                       <span class="at">beta =</span> <span class="fl">0.1</span>, <span class="co"># 1 - power</span></span>
<span id="cb2-11"><a href="#cb2-11" tabindex="-1"></a>                       <span class="at">w =</span> <span class="fl">0.6</span>, <span class="at">in1 =</span> <span class="dv">300</span>, <span class="at">in2 =</span> <span class="dv">600</span>, <span class="co">#weight and amount of information</span></span>
<span id="cb2-12"><a href="#cb2-12" tabindex="-1"></a>                       <span class="at">a =</span> <span class="fl">0.25</span>, <span class="at">b =</span> <span class="fl">0.75</span>) <span class="co">#truncation values</span></span></code></pre></div>
</div>
<div id="interpreting-the-output" class="section level2">
<h2>Interpreting the output</h2>
<p>After setting all these input parameters and running the function,
let’s take a look at the output of the program.</p>
<div class="sourceCode" id="cb3"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb3-1"><a href="#cb3-1" tabindex="-1"></a>res</span>
<span id="cb3-2"><a href="#cb3-2" tabindex="-1"></a><span class="co">#&gt; Optimization result:</span></span>
<span id="cb3-3"><a href="#cb3-3" tabindex="-1"></a><span class="co">#&gt;  Utility: 3147.32</span></span>
<span id="cb3-4"><a href="#cb3-4" tabindex="-1"></a><span class="co">#&gt;  Sample size:</span></span>
<span id="cb3-5"><a href="#cb3-5" tabindex="-1"></a><span class="co">#&gt;    phase II: 80, phase III: 188, total: 268</span></span>
<span id="cb3-6"><a href="#cb3-6" tabindex="-1"></a><span class="co">#&gt;  Probability to go to phase III: 0.99</span></span>
<span id="cb3-7"><a href="#cb3-7" tabindex="-1"></a><span class="co">#&gt;  Total cost:</span></span>
<span id="cb3-8"><a href="#cb3-8" tabindex="-1"></a><span class="co">#&gt;    phase II: 69, phase III: 155, cost constraint: Inf</span></span>
<span id="cb3-9"><a href="#cb3-9" tabindex="-1"></a><span class="co">#&gt;  Fixed cost:</span></span>
<span id="cb3-10"><a href="#cb3-10" tabindex="-1"></a><span class="co">#&gt;    phase II: 15, phase III: 20</span></span>
<span id="cb3-11"><a href="#cb3-11" tabindex="-1"></a><span class="co">#&gt;  Variable cost per patient:</span></span>
<span id="cb3-12"><a href="#cb3-12" tabindex="-1"></a><span class="co">#&gt;    phase II: 0.675, phase III: 0.72</span></span>
<span id="cb3-13"><a href="#cb3-13" tabindex="-1"></a><span class="co">#&gt;  Effect size categories (expected gains):</span></span>
<span id="cb3-14"><a href="#cb3-14" tabindex="-1"></a><span class="co">#&gt;   small: 0 (3000), medium: 0.5 (8000), large: 0.8 (10000)</span></span>
<span id="cb3-15"><a href="#cb3-15" tabindex="-1"></a><span class="co">#&gt;  Success probability: 0.85</span></span>
<span id="cb3-16"><a href="#cb3-16" tabindex="-1"></a><span class="co">#&gt;  Success probability by effect size:</span></span>
<span id="cb3-17"><a href="#cb3-17" tabindex="-1"></a><span class="co">#&gt;    small: 0.68, medium: 0.16, large: 0.01</span></span>
<span id="cb3-18"><a href="#cb3-18" tabindex="-1"></a><span class="co">#&gt;  Significance level: 0.025</span></span>
<span id="cb3-19"><a href="#cb3-19" tabindex="-1"></a><span class="co">#&gt;  Targeted power: 0.9</span></span>
<span id="cb3-20"><a href="#cb3-20" tabindex="-1"></a><span class="co">#&gt;  Decision rule threshold: 0.06 [Kappa] </span></span>
<span id="cb3-21"><a href="#cb3-21" tabindex="-1"></a><span class="co">#&gt;  Parameters of the prior distribution: </span></span>
<span id="cb3-22"><a href="#cb3-22" tabindex="-1"></a><span class="co">#&gt;    Delta1: 0.625, Delta2: 0.9, in1: 300, in2: 600,</span></span>
<span id="cb3-23"><a href="#cb3-23" tabindex="-1"></a><span class="co">#&gt;    a: 0.25, b: 0.75, w: 0.6</span></span>
<span id="cb3-24"><a href="#cb3-24" tabindex="-1"></a><span class="co">#&gt;  Treatment effect offset between phase II and III: 0 [gamma]</span></span></code></pre></div>
<p>The program returns a total of thirteen values and the input values.
Once again, we will only focus at the most important ones:</p>
<ul>
<li><code>res$n2</code> is the optimal sample size for phase II and
<code>res$n3</code> the resulting sample size for phase III. We see that
the optimal scenario requires 80 participants in phase II and 188
participants in phase III. The number of participants in both phases was
reduced compared to the setting with a fixed treatment effect.</li>
<li><code>res$Kappa</code> is the optimal threshold value for the
go/no-go decision rule. We see that we need a treatment effect of more
than 0.06 in phase II in order to proceed to phase III, which is the
same as in the baseline scenario.</li>
<li><code>res$u</code> is the expected utility of the program for the
optimal sample size and threshold value. In our case it amounts to
3147.32, i.e. we have an expected utility of 314 732 000$. This is a
6.83% increase over the scenario without the prior distribution. The
increase in the expected utility can be attributed to the additional
weight which was put on the second treatment effect <code>Delta2</code>,
which was more promising than our treatment effect.</li>
</ul>
<p>Of course, the differences in the output values compared to the fixed
setting heavily depend on the choice of the prior.</p>
</div>
</div>
<div id="prior-distributions-for-time-to-event-outcomes" class="section level1">
<h1>Prior distributions for time-to-event outcomes</h1>
<p>Note that in the setting of <a href="https://sterniii3.github.io/drugdevelopR/articles/Time-to-event_outcomes.html">time-to-event
outcomes</a>, the following input parameters have to be specified, which
differ from the setting with normally distributed outcomes:</p>
<ul>
<li>Instead of the parameters <code>in1</code> and <code>in2</code> for
the “amount of information”, we have to use the parameters
<code>id1</code> and <code>id2</code> which represent the “number of
events”. They refer to the number of events which were observed in the
study to determine the treatment effect. If in our study 210 events
could be observed, then the value for <code>id1</code> is set to be 210.
If we assume assume that in the study of the other research group 420
events could be observed, the parameter value for <code>id2</code> is
420.</li>
<li>Moreover, we do not need truncation values, i.e. values for the
parameters <code>a</code> and <code>b</code>.</li>
</ul>
</div>
<div id="where-to-go-from-here" class="section level1">
<h1>Where to go from here</h1>
<p>This tutorial explains how to use the parameters needed for the prior
distribution when setting the parameter <code>fixed</code> to be
<code>&quot;FALSE&quot;</code>.</p>
<p>For more information on how to use the package, see:</p>
<ul>
<li><a href="https://sterniii3.github.io/drugdevelopR/articles/Introduction-to-drugdevelopR.html"><em>Introduction
to drugdevelopR:</em></a> See how the package works in a basic
example.</li>
<li><em>Different outcomes:</em> Apply it to <a href="https://sterniii3.github.io/drugdevelopR/articles/Binary_outcomes.html">binary
endpoints</a> and <a href="https://sterniii3.github.io/drugdevelopR/articles/Time-to-event_outcomes.html">time-to-event
endpoints</a>.</li>
<li><a href="https://sterniii3.github.io/drugdevelopR/articles/Interpreting_Output.html"><em>Interpreting
the rest of the output:</em></a> Obtain further details on your drug
development program.</li>
<li><a href="https://sterniii3.github.io/drugdevelopR/articles/More_Parameters.html"><em>More
parameters:</em></a> Define custom effect size categories. Put
constraints on the optimization by defining maximum costs, the total
expected sample size of the program or the minimum expected probability
of a successful program. Define an expected difference in treatment
effect between phase II and III. Skip phase II.</li>
<li><em>Complex drug development programs:</em> Adapt to situations with
<a href="https://sterniii3.github.io/drugdevelopR/articles/Bias_adjustment.html">biased
effect estimators</a>, <a href="https://sterniii3.github.io/drugdevelopR/articles/Multitrial.html">multiple
phase III trials</a>, <a href="https://sterniii3.github.io/drugdevelopR/articles/Multiarm_Trials.html">multi-arm
trials</a>, or <a href="https://sterniii3.github.io/drugdevelopR/articles/Multiple_Endpoints.html">multiple
endpoints</a>.</li>
<li><a href="https://sterniii3.github.io/drugdevelopR/articles/More_Parameters.html#parallel-computing"><em>Parallel
computing:</em></a> Be faster at calculating the optimum by using
parallel computing.</li>
</ul>
</div>



<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
